Frank Takkinen Analyst PerformanceSenior Research Analyst at Lake Street CapitalFrank Takkinen is a stock analyst at Lake Street Capital focused in the healthcare sector, covering 25 publicly traded companies. Over the past year, Frank Takkinen has issued 28 stock ratings, including buy and hold recommendations. While full access to Frank Takkinen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Frank Takkinen's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings47 Last 6 YearsBuy Recommendations90.91% 40 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution44RatingsDistribution of strong buy, buy, hold, and sell ratings by Frank Takkinen.RatingPercentageCount Strong Buy0.0%0 ratings Buy90.9%40 ratings Hold9.1%4 ratings Sell0.0%0 ratingsOut of 44 total stock ratings issued by Frank Takkinen at Lake Street Capital, the majority (90.9%) have been Buy recommendations, followed by 9.1% Hold.Best & Worst CallsBest Call0000.0%SGHTAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NOTVMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ92.0% of companies on NASDAQ23 companiesNYSE8.0% of companies on NYSE2 companiesFrank Takkinen, an analyst at Lake Street Capital, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare24 companies96.0%Technology1 company4.0%Frank Takkinen of Lake Street Capital specializes in stock coverage within the Healthcare sector, with additional focus on Technology companies.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES23 companies92.0%PHARMACEUTICALS1 company4.0%SOFTWARE1 company4.0% Frank Takkinen's Ratings History at Lake Street Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCOCHEnvoy Medical10/6/2026Initiated Coverage$0.65$2.50Buy$0.0000.00% ROIAXGNAxoGen10/5/2026Reiterated Rating$37.75Buy$0.0000.00% ROIXAIRBeyond Air9/1/2026Initiated Coverage$3.97$10.00Buy$0.0000.00% ROIRCELAvita Medical8/28/2026Boost Price Target$10.60$12.00Buy$0.0000.00% ROICVRXCVRx8/7/2026Downgrade$5.94$3.50Hold$0.0000.00% ROISMTISanara MedTech7/30/2026Downgrade$33.92$35.00Hold$0.0000.00% ROIRCELAvita Medical5/15/2026Upgrade$4.36$6.00Buy$0.0000.00% ROITLSITriSalus Life Sciences5/13/2026Lower Price Target$2.37$8.00Buy$0.0000.00% ROIAXGNAxoGen4/23/2026Boost Price Target$37.32$50.00Buy$0.0000.00% ROISMTISanara MedTech4/15/2026Initiated Coverage$18.51$32.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TELATELA Bio3/25/2026Lower Price Target$0.71$2.00Buy$0.0000.00% ROIHYPRHyperfine3/19/2026Boost Price Target$1.21$2.50Buy$0.0000.00% ROINSPRInspireMD2/24/2026Set Price Target$1.78$5.00$0.0000.00% ROITNDMTandem Diabetes Care2/23/2026Upgrade$24.57$50.00Buy$0.0000.00% ROIBBNXBeta Bionics2/18/2026Set Price Target$11.93$20.00$0.0000.00% ROINOTVInotiv2/10/2026Lower Price Target$0.34$1.50Buy$0.0000.00% ROIAVRAnteris Technologies Global1/23/2026Reiterated Rating$6.46$15.00Buy$0.0000.00% ROIRCELAvita Medical1/16/2026Boost Price Target$3.46$3.50Hold$0.0000.00% ROIBBNXBeta Bionics1/9/2026Boost Price Target$31.99$40.00Buy$0.0000.00% ROIKRMDKORU Medical Systems12/22/2025Boost Price Target$5.80$8.00Buy$0.0000.00% ROIAXGNAxoGen12/4/2025Boost Price Target$28.33$40.00Buy$0.0000.00% ROINOTVInotiv12/4/2025Lower Price Target$0.94$3.00Buy$0.0000.00% ROIADGMAdagio Medical12/2/2025Initiated Coverage$0.97$4.00Buy$0.0000.00% ROITELATELA Bio12/1/2025Set Price Target$1.15$3.00$0.0000.00% ROITELATELA Bio12/1/2025Lower Price Target$1.24$3.00Buy$0.0000.00% ROIBBNXBeta Bionics10/29/2025Reiterated Rating$24.28$35.00Buy$0.0000.00% ROILUNGPulmonx10/28/2025Lower Price Target$2.46$4.00Buy$0.0000.00% ROISGHTSight Sciences10/21/2025Boost Price Target$4.58$7.00Buy$0.0000.00% ROIELUTElutia9/10/2025Lower Price Target$1.35$6.00Buy$0.0000.00% ROIHYPRHyperfine8/14/2025Boost Price Target$1.47$2.00Buy$0.0000.00% ROISGHTSight Sciences8/8/2025Upgrade$3.55$5.00Buy$0.0000.00% ROIINSPInspire Medical Systems8/5/2025Set Price Target$77.62$150.00Buy$00.0000.00% ROILUNGPulmonx7/31/2025Lower Price Target$1.84$8.00Buy$0.0000.00% ROIANGOAngioDynamics7/16/2025Initiated Coverage$8.66$24.00Buy$00.0000.00% ROIELUTElutia5/9/2025Lower Price Target$1.99$8.00Buy$0.0000.00% ROINOTVInotiv5/8/2025Lower Price Target$2.33$5.00Buy$0.0000.00% ROICVRXCVRx4/8/2025Lower Price Target$6.20$14.00Buy$0.0000.00% ROIHYPRHyperfine3/24/2025Initiated Coverage$0.82$1.50Buy$0.0000.00% ROILNSRLENSAR3/24/2025Reiterated Rating$14.40$15.00Hold$0.0000.00% ROIAXGNAxoGen3/17/2025Initiated Coverage$17.25$30.00Buy$00.0000.00% ROIThis list won't be up much longer (Ad)Bill Poulos and his team rebuild their Top 10 Stocks to Buy This Quarter report from scratch every quarter, pulling the old list down the moment a new one goes up. This quarter's edition is still available, but once the next list is published, it disappears for good. Normally priced at 29.97 dollars, it's currently free to download.Download this quarter's free Top 10 Stocks report nowLNSRLENSAR2/28/2025Boost Price Target$12.18$16.00Buy$00.0000.00% ROICLBTCellebrite DI2/14/2025Boost Price Target$20.43$26.00Buy$00.0000.00% ROICLPTClearPoint Neuro1/21/2025Boost Price Target$17.60$30.00Buy$00.0000.00% ROIKRMDKORU Medical Systems1/14/2025Boost Price Target$3.88$5.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyMorgan StanleyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
